Comparative screening for thyroid disorders in old age in areas of iodine deficiency, long-term iodine prophylaxis and abundant iodine intake. 1997

I Szabolcs, and J Podoba, and J Feldkamp, and O Dohan, and I Farkas, and M Sajgó, and K I Takáts, and M Góth, and L Kovács, and K Kressinszky, and P Hnilica, and G Szilágyi
1st Department of Medicine, Haynal Imre University of Health Sciences, Budapest, Hungary.

OBJECTIVE To investigate the effect of varying amounts of iodine intake on the prevalence of thyroid dysfunction, autoimmunity and goitre in old age. METHODS The first screening study where elderly subjects with varying amounts of iodine supply but from the same geographical and ethnographical region (Carpathian basin) were compared, and all hormone measurements and ultrasonography were performed by the same laboratory or person. METHODS Nursing home residents were screened for thyroid disorders from: (A) an iodine-deficient area, Northern Hungary (n = 119; median age 81 years; median iodine excretion (MIE) 0.065 mumol/mmol creatinine (equivalent to 72 micrograms/g creatinine); (B) an area of obligatory iodinated salt prophylaxis since the 1950s, Slovakia (n = 135; median age 81 years, MIE 0.090 mumol/mmol creatinine (equivalent to 100 micrograms/g creatinine)) and (C) an abundant iodine intake area, Eastern Hungary (n = 92; median age 78 years; MIE 0.462 mumol/mmol creatinine (equivalent to 513 micrograms/g creatinine)). METHODS TSH, T4, free T4, T3, thyroglobulin (Tg), antibodies to Tg (AbTg) and to thyroid peroxidase (AbTPO), iodine excretion, ultrasonography of the thyroid gland. RESULTS In regions A, B, and C, the prevalence of unsuspected clinical hypothyroidism was 0.8%, 1.5% and 7.6% (P = 0.006), with all cases except one being antibody positive (Ab+). The occurrence of subclinical hypothyroidism was 4.2% in region A, 10.4% in region B and 23.9% in region C (P < 0.001), but only 3 of 22 cases with subclinical hypothyroidism from region C were Ab+. The overall prevalence of Ab positivity (either antiTg+ or antiTPO+) was similar in the three regions (A, 19.3%; B, 24.4%; C, 22.8%). The occurrence of hyperthyroidism (clinical plus subclinical) was 3.4% in region A, 3.0% in region B and 0% in region C (not significant). The rate of elevated Tg levels was similar in the three regions. The prevalence of goitre was 39.4%, 16.4% and 12.2% (P < 0.001), respectively in regions A, B and C. In euthyroid subjects the mean ultrasonographically determined thyroid volume was 21.9 ml in region A, 13.6 ml in region B and 15.1 ml in region C (ANOVA F = 5.76; P = 0.0038). There was no significant difference in the occurrence of cases with hypoechogenic echotexture of the thyroid gland. CONCLUSIONS The screening for hypothyroidism in nursing home residents living in iodine-rich regions is justified by the high prevalence of unsuspected clinical hypothyroidism. The high prevalence of antibody positivity in old age is independent of the iodine supply, but iodine supply has a determining role in the development of autoimmune hypothyroidism in the aged. Most cases of subclinical hypothyroidism in iodine-rich regions are not of autoimmune origin. In old age, hypoechogenic texture of the thyroid gland is not predictive of thyroid dysfunction.

UI MeSH Term Description Entries
D007037 Hypothyroidism A syndrome that results from abnormally low secretion of THYROID HORMONES from the THYROID GLAND, leading to a decrease in BASAL METABOLIC RATE. In its most severe form, there is accumulation of MUCOPOLYSACCHARIDES in the SKIN and EDEMA, known as MYXEDEMA. It may be primary or secondary due to other pituitary disease, or hypothalamic dysfunction. Central Hypothyroidism,Primary Hypothyroidism,Secondary Hypothyroidism,TSH Deficiency,Thyroid-Stimulating Hormone Deficiency,Central Hypothyroidisms,Deficiency, TSH,Deficiency, Thyroid-Stimulating Hormone,Hormone Deficiency, Thyroid-Stimulating,Hypothyroidism, Central,Hypothyroidism, Primary,Hypothyroidism, Secondary,Hypothyroidisms,Primary Hypothyroidisms,Secondary Hypothyroidisms,TSH Deficiencies,Thyroid Stimulating Hormone Deficiency,Thyroid-Stimulating Hormone Deficiencies
D007455 Iodine A nonmetallic element of the halogen group that is represented by the atomic symbol I, atomic number 53, and atomic weight of 126.90. It is a nutritionally essential element, especially important in thyroid hormone synthesis. In solution, it has anti-infective properties and is used topically. Iodine-127,Iodine 127
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D005260 Female Females
D006042 Goiter Enlargement of the THYROID GLAND that may increase from about 20 grams to hundreds of grams in human adults. Goiter is observed in individuals with normal thyroid function (euthyroidism), thyroid deficiency (HYPOTHYROIDISM), or hormone overproduction (HYPERTHYROIDISM). Goiter may be congenital or acquired, sporadic or endemic (GOITER, ENDEMIC). Goiters
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006814 Hungary A country in Europe, northwest of Romania, south of Slovakia, and east of Austria. The capital is Budapest.
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

I Szabolcs, and J Podoba, and J Feldkamp, and O Dohan, and I Farkas, and M Sajgó, and K I Takáts, and M Góth, and L Kovács, and K Kressinszky, and P Hnilica, and G Szilágyi
January 2012, Maturitas,
I Szabolcs, and J Podoba, and J Feldkamp, and O Dohan, and I Farkas, and M Sajgó, and K I Takáts, and M Góth, and L Kovács, and K Kressinszky, and P Hnilica, and G Szilágyi
April 2015, The lancet. Diabetes & endocrinology,
I Szabolcs, and J Podoba, and J Feldkamp, and O Dohan, and I Farkas, and M Sajgó, and K I Takáts, and M Góth, and L Kovács, and K Kressinszky, and P Hnilica, and G Szilágyi
February 2012, Pathology,
I Szabolcs, and J Podoba, and J Feldkamp, and O Dohan, and I Farkas, and M Sajgó, and K I Takáts, and M Góth, and L Kovács, and K Kressinszky, and P Hnilica, and G Szilágyi
November 2000, Thyroid : official journal of the American Thyroid Association,
I Szabolcs, and J Podoba, and J Feldkamp, and O Dohan, and I Farkas, and M Sajgó, and K I Takáts, and M Góth, and L Kovács, and K Kressinszky, and P Hnilica, and G Szilágyi
December 2006, Zhonghua yi xue za zhi,
I Szabolcs, and J Podoba, and J Feldkamp, and O Dohan, and I Farkas, and M Sajgó, and K I Takáts, and M Góth, and L Kovács, and K Kressinszky, and P Hnilica, and G Szilágyi
September 1994, East African medical journal,
I Szabolcs, and J Podoba, and J Feldkamp, and O Dohan, and I Farkas, and M Sajgó, and K I Takáts, and M Góth, and L Kovács, and K Kressinszky, and P Hnilica, and G Szilágyi
September 1973, Deutsche medizinische Wochenschrift (1946),
I Szabolcs, and J Podoba, and J Feldkamp, and O Dohan, and I Farkas, and M Sajgó, and K I Takáts, and M Góth, and L Kovács, and K Kressinszky, and P Hnilica, and G Szilágyi
November 1994, Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine],
I Szabolcs, and J Podoba, and J Feldkamp, and O Dohan, and I Farkas, and M Sajgó, and K I Takáts, and M Góth, and L Kovács, and K Kressinszky, and P Hnilica, and G Szilágyi
September 2001, Journal of internal medicine,
I Szabolcs, and J Podoba, and J Feldkamp, and O Dohan, and I Farkas, and M Sajgó, and K I Takáts, and M Góth, and L Kovács, and K Kressinszky, and P Hnilica, and G Szilágyi
September 2014, Endocrinology and metabolism (Seoul, Korea),
Copied contents to your clipboard!